|
시장보고서
상품코드
1912160
BMP 2(골형성 단백질 2) 시장(2025년)Global Bone Morphogenetic Protein (BMP) 2 Market Research Report 2025 |
||||||
세계의 BMP 2(골형성 단백질 2) 시장은 2024년 6억 9,700만 달러로 평가되었으며, 2031년까지 11억 2,000만 달러에 이를 것으로 예측됩니다.
이에 따라 2025년부터 2031년까지의 예측 기간에서 CAGR 6.77%를 기록할 전망입니다.
북미의 BMP 2(골형성 단백질 2) 시장은 2024년 4억 7,676만 달러에서 2031년까지 7억 5,400만 달러에 이를 것으로 예측되며, 2025년에서 2031년의 예측 기간 동안 CAGR 6.09%로 성장할 것으로 전망됩니다.
아시아태평양의 BMP 2(골형성 단백질 2) 시장은 2024년 1억 4,047만 달러에서 2031년까지 2억 5,059만 달러에 이를 것으로 예측되며, 2025년에서 2031년의 예측 기간 동안 CAGR 10.26%로 성장할 것으로 전망됩니다.
세계의 BMP 2(골형성 단백질 2) 시장의 주요 기업에는 Medtronic, Jiuyuan Gene Engineering, Cellumed 등이 있습니다. 2024년 기준으로 세계 3대 벤더의 수익 점유율은 약 98.84%를 차지했습니다.
본 보고서는 세계의 BMP 2(골형성 단백질 2) 시장에 대해 정량적 및 정성적 분석을 겸비한 종합적인 제시를 실시하는 것을 목적으로 하고 있습니다. 이에 따라, 독자의 BMP 2에 관한 사업 및 성장 전략 책정, 시장 경쟁 구도의 평가, 현행 마켓플레이스에서의 자사의 위치 분석, 그리고 정보에 근거한 사업 판단을 뒷받침합니다.
BMP 2(골형성 단백질 2) 시장의 규모, 추정 및 예측치는 2024년을 기준연도로 하여 2020년부터 2031년까지의 기간 동안의 과거 데이터와 예측 데이터에 근거해 수익(백만 달러) 단위로 제공됩니다. 본 보고서에서는 세계의 BMP 2(골형성 단백질 2) 시장을 종합적으로 세분화하고 있습니다. 지역별 시장 규모, 제품 유형별, 용도별 및 주요 기업별 시장 규모에 대해서도 제시합니다.
시장에 대한 깊은 이해를 위해 본 보고서는 경쟁 구도, 주요 경쟁사 및 각 시장 순위에 대한 프로파일을 제공합니다. 또한 기술 동향과 신제품 개발에 대해서도 논의했습니다.
본 보고서는 BMP 2(골형성 단백질 2) 관련 기업, 신규 진출기업 및 업계 체인 관련 기업에 대해 시장 전체 및 각 하위 부문(기업별, 유형별, 용도별, 지역별)의 수익에 관한 정보를 제공하여 시장 진입을 뒷받침합니다.
시장 세분화
기업별
유형별 부문
용도별 부문
지역별 부문
The global Bone Morphogenetic Protein (BMP) 2 market was valued at US$ 697 million in 2024 and is anticipated to reach US$ 1120 million by 2031, witnessing a CAGR of 6.77% during the forecast period 2025-2031.
North American market for Bone Morphogenetic Protein (BMP) 2 is estimated to increase from $ 476.76 million in 2024 to reach $ 754 million by 2031, at a CAGR of 6.09% during the forecast period of 2025 through 2031.
Asia-Pacific market for Bone Morphogenetic Protein (BMP) 2 is estimated to increase from $ 140.47 million in 2024 to reach $ 250.59 million by 2031, at a CAGR of 10.26% during the forecast period of 2025 through 2031.
The major global companies of Bone Morphogenetic Protein (BMP) 2 include Medtronic, Jiuyuan Gene Engineering, Cellumed, etc. In 2024, the world's top three vendors accounted for approximately 98.84% of the revenue.
This report aims to provide a comprehensive presentation of the global market for Bone Morphogenetic Protein (BMP) 2, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bone Morphogenetic Protein (BMP) 2.
The Bone Morphogenetic Protein (BMP) 2 market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bone Morphogenetic Protein (BMP) 2 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bone Morphogenetic Protein (BMP) 2 companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Segment by Type
Segment by Application
Segment by Region
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bone Morphogenetic Protein (BMP) 2 company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.